Bo Ahrén

81 – 90 of 398

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/af6f8d38-a95b-47b6-9ec5-5f69aa8d0e59?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
8
9
10
11
…
40
next »

2015
Mark Incretin and islet hormone responses to meals of increasing size in healthy subjects.
Alsalim, Wathik ^LU ; Omar, Bilal ^LU ; Pacini, Giovanni ; Bizzotto, Roberto ; Mari, Andrea and Ahrén, Bo ^LU (2015) In Journal of Clinical Endocrinology and Metabolism 100(2). p.561-568
- Contribution to journal › Article
Mark Creative use of novel glucose-lowering drugs for type 2 diabetes: where will we head in the next 50 years?
Ahrén, Bo ^LU (2015) In Diabetologia 58(8). p.1740-1744
- Contribution to journal › Debate/Note/Editorial
Mark Physiological aspects of the combination of insulin and GLP-1 in the regulation of blood glucose control.
Ahrén, Bo ^LU (2015) In Diabetes & Metabolism 41(6 Suppl 1). p.3-8
- Contribution to journal › Article
Mark Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes: A Randomized Clinical Trial.
Jakubowicz, Daniela ; Wainstein, Julio ; Ahrén, Bo ^LU ; Landau, Zohar ; Bar-Dayan, Yosefa and Froy, Oren (2015) In Diabetes Care 38(10). p.1820-1826
- Contribution to journal › Article
Mark Hepato-Incretin Function of GLP-1: Novel Concept and Target in Type 1 Diabetes.
Ahrén, Bo ^LU (2015) In Diabetes 64(3). p.715-717
- Contribution to journal › Debate/Note/Editorial
2014
Mark Impact of glucose dosing regimens on modeling of glucose tolerance and β-cell function by intravenous glucose tolerance test in diet-induced obese mice.
Omar, Bilal ^LU ; Pacini, Giovanni and Ahrén, Bo ^LU (2014) In Physiological Reports 2(5).
- Contribution to journal › Article
Mark Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?
Ahrén, Bo ^LU ; Foley, James Edward ; Dejager, Sylvie ; Akacha, Mouna ; Shao, Qing ; Heimann, Guenter ; Dworak, Markus and Schweizer, Anja (2014) In Diabetes therapy : research, treatment and education of diabetes and related disorders
- Contribution to journal › Article
Mark GLP-1 released to the mesenteric lymph duct in mice: Effects of glucose and fat.
Ohlsson, Lena ^LU ; Kohan, Alison B ; Tso, Patrick and Ahrén, Bo ^LU (2014) In Regulatory Peptides 189(Feb 28). p.40-45
- Contribution to journal › Article
Mark Fibroblast Growth Factor 21 (FGF21) and Glucagon Like-Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor Deficient Mice.
Omar, Bilal ^LU ; Andersen, Birgitte ; Hald, Jacob ; Raun, Kirsten ; Nishimura, Erica and Ahrén, Bo ^LU (2014) In Diabetes 63(1). p.101-110
- Contribution to journal › Article
Mark The neuro-incretin concept.
Ahrén, Bo ^LU (2014) In Regulatory Peptides 194(Sep 16). p.3-5
- Contribution to journal › Debate/Note/Editorial

« previous
1
…
8
9
10
11
…
40
next »